Loading clinical trials...

Correction of Anisometropic Amblyopia in Children. | Clinical Trials | Clareo Health

UNKNOWN

Correction of Anisometropic Amblyopia in Children.

Correction of Anisometropic Amblyopia in Children at School Age.

NCT05325021•Benha University

View on ClinicalTrials.gov

Summary

Anisometropic amblyopia among children in school age may affects quality of life and educational progress of children.

Detailed Description

Correction of anisometropic amblyopia depends on type of refractive error and axial length of the eye. In this study, we will asses the types of anisometropia found in children at school age and investigate possible ways for correction of this type of amblyopia.

Eligibility

Age

4 - 12 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Anisometropic amblyopia.
•Children at school age ranged from 4 to 12 years old.

Exclusion Criteria

•Emmetropia children.
•Children had undergone any intraocular surgeries.
•Other types of amblyopia.

Locations (1)

Ahmed Abdelshafy Tabl

Banhā, Benha, Egypt

Key Dates

Start Date

April 2, 2022

Primary Completion Date

September 30, 2022

Completion Date

September 30, 2022

Last Updated

April 13, 2022

Enrollment

200

ESTIMATED participants

Conditions

AmblyopiaAnisometropic AmblyopiaAnisometropia and AniseikoniaRefractive Errors

Interventions

Axial length measurement in millimeter (mm) by optical biometry device

DIAGNOSTIC_TEST

Autorefractometer to measure the refractive error in both eyes.

DIAGNOSTIC_TEST

Contacts

Ahmed A Tabl, MD

CONTACT

01222328766 ahmad4lg@gmail.com

Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups.

NCT07417046

AmblyopiaVEP

View study

RECRUITINGPHASE3

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

NCT04378790

Amblyopia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Correction of Anisometropic Amblyopia in Children.

Inclusion Criteria

Exclusion Criteria

Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups.

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Patch-free Occlusion Therapy

Novel Amblyopia Treatment With Virtual Reality Games

Binocular Visual Therapy and Video Games for Amblyopia Treatment.